biotech news today glp-1 The arms race just got a new contender. Structure Therapeutics' oral pill aleniglipron cleared a mid-stage trial with clinically meaningful weight loss and a clean safety profile. Phase 3 is now Could one shot replace weekly
Description
In vitro studies have shown that monomeric flavanols stimulate ghrelin secretion, while oligomeric flavanols and gallic acid inhibit it (7577)
Therapy, medication management, and hormone evaluation because mental health is physical health
Despite this, payers remain conflicted on whether pharmaceutical treatment for obesity should be covered
However, it is crucial to note that although adverse impacts have been documented with DPP4is, they are typically infrequent and could be categorized as either classwide effects or specific undesirable effects limited to individual DPP4is
[65] References 3
